HomeCompareBKFCF vs JNJ

BKFCF vs JNJ: Dividend Comparison 2026

BKFCF yields 5.65% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKFCF wins by $12401.23M in total portfolio value
10 years
BKFCF
BKFCF
● Live price
5.65%
Share price
$0.88
Annual div
$0.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12401.26M
Annual income
$11,993,468,103.34
Full BKFCF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BKFCF vs JNJ

📍 BKFCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKFCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKFCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKFCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKFCF
Annual income on $10K today (after 15% tax)
$480.24/yr
After 10yr DRIP, annual income (after tax)
$10,194,447,887.84/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, BKFCF beats the other by $10,194,443,901.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKFCF + JNJ for your $10,000?

BKFCF: 50%JNJ: 50%
100% JNJ50/50100% BKFCF
Portfolio after 10yr
$6200.65M
Annual income
$5,996,736,396.37/yr
Blended yield
96.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BKFCF
No analyst data
Altman Z
0.2
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKFCF buys
0
JNJ buys
0
No recent congressional trades found for BKFCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKFCFJNJ
Forward yield5.65%2.13%
Annual dividend / share$0.05$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$12401.26M$30.3K
Annual income after 10y$11,993,468,103.34$4,689.40
Total dividends collected$12372.90M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BKFCF vs JNJ ($10,000, DRIP)

YearBKFCF PortfolioBKFCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,830$1,129.99$10,592$272.30+$1.2KBKFCF
2$15,157$2,498.64$11,289$357.73+$3.9KBKFCF
3$22,201$5,983.71$12,123$472.89+$10.1KBKFCF
4$40,138$16,382.95$13,141$629.86+$27.0KBKFCF
5$98,311$55,362.85$14,408$846.81+$83.9KBKFCF
6$358,651$253,458.07$16,021$1,151.60+$342.6KBKFCF
7$2,112,068$1,728,311.77$18,122$1,588.22+$2.09MBKFCF
8$21,284,025$19,024,112.05$20,930$2,228.20+$21.26MBKFCF
9$381,114,860$358,340,952.85$24,792$3,191.91+$381.09MBKFCF
10$12,401,261,003$11,993,468,103.34$30,274$4,689.40+$12401.23MBKFCF

BKFCF vs JNJ: Complete Analysis 2026

BKFCFStock

Bank of Communications Co., Ltd. provides commercial banking products and services. The company operates through four business segments: Corporate Banking, Personal Banking, Treasury Businesses, and Other Businesses. It offers personal banking products and services, including savings deposit products, personal certificate of deposits, foreign currency deposit, and salary financing A products; mortgage and unsecured loans; bank cards; airport and personal wealth management advisor services; and physical precious metals, and structured deposits and wealth management products, as well as precious metal and commodity trading services. The company also provides corporate banking products and services comprising structured deposits and corporate certificate of deposits; syndicated loans and corporation overdraft services; wealth management services; investment banking and offshore banking services; corporate cash management and industrial chain financing services; structured deposits and wealth management products; and precious metal leasing, and precious metal and commodity trading services. In addition, it offers international banking services, such as corporate forex wealth management, document settlement, remittance and bill, and trade finance services; and interbank financing services. Further, the company provides financial leasing, trust investment, fund management, life insurance, securities dealing and brokerage, general insurance and reinsurance, debt-to-equity swaps, and financial products issuing and financial consulting services. As of December 31, 2021, It operated 248 branches in Mainland China; and 23 overseas branches and representative offices in 18 countries and regions with 69 overseas operating outlets. The company was founded in 1908 and is headquartered in Shanghai, the People's Republic of China.

Full BKFCF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BKFCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKFCF vs SCHDBKFCF vs JEPIBKFCF vs OBKFCF vs KOBKFCF vs MAINBKFCF vs ABBVBKFCF vs MRKBKFCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.